CHRISTIE HEANY: Open Payments
NPI 1518150119 · GIG HARBOR, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$954 in 40 payments from 17 companies in 2025. Trend: 2023 $524 · 2024 $539 · 2025 $954
Food & beverage: $954
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 5 | $265 |
| ABBVIE INC. | 9 | $135 |
| PFIZER INC. | 5 | $132 |
| Novo Nordisk Inc | 3 | $62 |
| Lilly USA, LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Insulet Corporation | 1 | $26 |
Products named: Korlym, NURTEC ODT, QULIPTA, Wegovy, MAVYRET, MOUNJARO, CAPVAXIVE, PREVNAR 20.
Industry payments across WA — which companies pay providers there.
